Table 1.
Intervention | Background | Sex | Number of mice | % increase in median survival | Reference |
---|---|---|---|---|---|
GHRKO | C57BL/6 | Male | 9 | 30 | Bonkowski et al. (2006) [15] |
Female | 9 | 30 | |||
Wild type (control) | Male | 10 | - | ||
Female | 10 | - | |||
Snell DW | DW×C3H | Male | 10 | 42 | Flurkey et al. (2001) [16] |
Female | 9 | 42 | |||
Wild type (control) | Male | 12 | - | ||
Female | 9 | - | |||
Calorie restriction | UM-HET3 | Male | 14 | 32 | Flurkey et al. (2010) [17] |
Female | 12 | 40 | |||
Rapamycin | Male | 14 | 13 | Miller et al. (2014) [18] | |
Female | 13 | 21 | |||
Acarbose | Male | 14 | 22 | Harrison et al. (2014) [5] | |
Female | 13 | 5 | |||
Canagliflozin | Male | 14 | 14 | Miller et al. (2020) [7] | |
Female | 13 | 1 | |||
17α-estradiol | Male | 14 | 12 | Harrison et al. (2014) [5] | |
Female | 13 | 0 | |||
Untreated (control) | Male | 26 | - | ||
Female | 26 | - |